Home › Companies › ADAPTIVE BIOTECHNOLOGIES CORP. › 2023-2024
Compiled from SEC Form N-PX filings. Page generated October 18, 2026.
No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from ADAPTIVE BIOTECHNOLOGIES CORP. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore ADAPTIVE BIOTECHNOLOGIES CORP. in the interactive database Compare manager voting policies
Each item below shows how the 202 asset managers that disclosed a ADAPTIVE BIOTECHNOLOGIES CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ADAPTIVE BIOTECHNOLOGIES CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
60% of fund votes cast · no official result
Description as filed by funds: To elect two Class II director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2027 annual meeting of shareholders: Peter Neupert
The 58 asset managers below reported 23,845,865 for, 15,683,447 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,805,116 | 0 | 0 | 0 | For |
| ARK ETF Trust | 10,319,635 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 0 | 3,329,532 | Withhold |
| BlackRock | 0 | 0 | 0 | 2,940,769 | Withhold |
| Fidelity | 0 | 0 | 0 | 2,437,190 | Withhold |
| Aberdeen | 0 | 0 | 0 | 1,029,447 | Withhold |
| Federated Hermes | 0 | 0 | 0 | 910,597 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 870,224 | Withhold |
| Aristotle Funds Series Trust | 0 | 0 | 0 | 829,708 | Withhold |
| Dimensional | 0 | 0 | 0 | 704,002 | Withhold |
| TIAA | 0 | 0 | 0 | 549,742 | Withhold |
| Prudential/PGIM | 112,612 | 0 | 0 | 237,483 | Mixed |
| Equitable | 0 | 0 | 0 | 292,368 | Withhold |
| Pacific Life | 0 | 0 | 0 | 291,982 | Withhold |
| Putnam | 219,346 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 0 | 190,752 | Withhold |
| Dunham Funds | 117,346 | 0 | 0 | 0 | For |
| Lincoln Financial | 2,369 | 0 | 0 | 107,207 | Withhold |
| PRIMECAP Odyssey Funds | 104,230 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 101,932 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 0 | 0 | 0 | 90,980 | Withhold |
| T. Rowe Price | 0 | 0 | 0 | 80,946 | Withhold |
| 1290 Funds | 0 | 0 | 0 | 71,325 | Withhold |
| Northern Trust | 0 | 0 | 0 | 70,987 | Withhold |
| JPMorgan | 63,211 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 4 wordings of this item as funds reported it.
82% of fund votes cast · no official result
Description as filed by funds: To elect two Class II director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2027 annual meeting of shareholders: Michelle Griffin
The 58 asset managers below reported 32,315,659 for, 7,213,653 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,805,116 | 0 | 0 | 0 | For |
| ARK ETF Trust | 10,319,635 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 0 | 3,329,532 | Withhold |
| BlackRock | 2,940,769 | 0 | 0 | 0 | For |
| Fidelity | 2,329,782 | 0 | 0 | 107,408 | For |
| Aberdeen | 0 | 0 | 0 | 1,029,447 | Withhold |
| Federated Hermes | 910,597 | 0 | 0 | 0 | For |
| Charles Schwab | 870,224 | 0 | 0 | 0 | For |
| Aristotle Funds Series Trust | 0 | 0 | 0 | 829,708 | Withhold |
| Dimensional | 0 | 0 | 0 | 704,002 | Withhold |
| TIAA | 549,742 | 0 | 0 | 0 | For |
| Prudential/PGIM | 112,612 | 0 | 0 | 237,483 | Mixed |
| Equitable | 177,172 | 0 | 0 | 115,196 | Mixed |
| Pacific Life | 39,796 | 0 | 0 | 252,186 | Mixed |
| Putnam | 219,346 | 0 | 0 | 0 | For |
| Goldman Sachs | 190,752 | 0 | 0 | 0 | For |
| Dunham Funds | 117,346 | 0 | 0 | 0 | For |
| Lincoln Financial | 100,469 | 0 | 0 | 9,107 | Mixed |
| PRIMECAP Odyssey Funds | 104,230 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 101,932 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 0 | 0 | 0 | 90,980 | Withhold |
| T. Rowe Price | 0 | 0 | 0 | 80,946 | Withhold |
| 1290 Funds | 0 | 0 | 0 | 71,325 | Withhold |
| Northern Trust | 70,987 | 0 | 0 | 0 | For |
| JPMorgan | 63,211 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 9 wordings of this item as funds reported it.
84% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement;
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,777,016 | 28,100 | 0 | 0 | For |
| ARK ETF Trust | 10,319,635 | 0 | 0 | 0 | For |
| MFS | 3,329,532 | 0 | 0 | 0 | For |
| BlackRock | 0 | 2,940,769 | 0 | 0 | Against |
| Fidelity | 2,387,740 | 49,450 | 0 | 0 | For |
| Aberdeen | 0 | 1,029,447 | 0 | 0 | Against |
| Federated Hermes | 0 | 910,597 | 0 | 0 | Against |
| Charles Schwab | 0 | 870,224 | 0 | 0 | Against |
| Aristotle Funds Series Trust | 829,708 | 0 | 0 | 0 | For |
| Dimensional | 0 | 704,002 | 0 | 0 | Against |
| TIAA | 549,742 | 0 | 0 | 0 | For |
| Prudential/PGIM | 237,483 | 112,612 | 0 | 0 | Mixed |
| Equitable | 115,196 | 177,172 | 0 | 0 | Mixed |
| Pacific Life | 252,186 | 39,796 | 0 | 0 | Mixed |
| Putnam | 0 | 219,346 | 0 | 0 | Against |
| Goldman Sachs | 190,752 | 0 | 0 | 0 | For |
| Dunham Funds | 117,346 | 0 | 0 | 0 | For |
| Lincoln Financial | 98,100 | 11,476 | 0 | 0 | Mixed |
| PRIMECAP Odyssey Funds | 0 | 104,230 | 0 | 0 | Against |
| RBB FUND, INC. | 101,932 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 90,980 | 0 | 0 | 0 | For |
| T. Rowe Price | 80,946 | 0 | 0 | 0 | For |
| 1290 Funds | 71,325 | 0 | 0 | 0 | For |
| Northern Trust | 70,987 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 63,211 | 0 | 0 | Against |
Fund voting reports, all 58 managers: 32,048,827 for, 7,457,597 against, 22,888 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 29,993,708 | 0 | 0 | 0 | For |
| Rubric Capital Management LP | 10,119,845 | 0 | 0 | 0 | For |
| Matrix Capital Management Company, LP | 5,522,318 | 0 | 0 | 0 | For |
| Nikko Asset Management Americas, Inc. | 4,182,393 | 0 | 0 | 0 | For |
| BlackRock | 123,634 | 3,953,586 | 0 | 0 | Against |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3,819,201 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,440,002 | 0 | 0 | 0 | For |
| State Street | 2,252,732 | 0 | 0 | 0 | For |
| Nikko Asset Management Co., Ltd. | 1,994,314 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,744,107 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 1,510,880 | 0 | 0 | Against |
| Federated Hermes | 0 | 1,311,888 | 0 | 0 | Against |
| Aristotle Atlantic Partners, LLC | 1,130,704 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 1,029,447 | 0 | 0 | Against |
| BRAIDWELL LP | 969,346 | 0 | 0 | 0 | For |
| Putnam | 0 | 958,660 | 0 | 0 | Against |
| Charles Schwab | 0 | 870,547 | 0 | 0 | Against |
| DDD Partners, LLC | 0 | 744,985 | 0 | 0 | Against |
| Pier Capital, LLC | 651,089 | 0 | 0 | 0 | For |
| Northern Trust | 594,860 | 78 | 0 | 0 | For |
| Nuveen | 553,761 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 530,451 | 0 | 0 | 0 | For |
| Dimensional | 0 | 312,116 | 0 | 0 | Against |
| Goldman Sachs | 270,843 | 0 | 0 | 0 | For |
| Vanguard | 267,782 | 0 | 0 | 0 | For |
Institutional-manager reports, all 162 managers: 69,452,196 for, 11,836,650 against, 7,524 not voted, 214 unknown. Showing the 25 largest; see all in the interactive database.
2% of fund votes cast · no official result
The 3 asset managers below reported 21,608 for, 974,170 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 859,214 | 0 | 0 | Against |
| JPMorgan | 0 | 114,956 | 0 | 0 | Against |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 21,608 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2024; and
The 58 asset managers below reported 39,506,424 for, 22,888 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,805,116 | 0 | 0 | 0 | For |
| ARK ETF Trust | 10,319,635 | 0 | 0 | 0 | For |
| MFS | 3,329,532 | 0 | 0 | 0 | For |
| BlackRock | 2,940,769 | 0 | 0 | 0 | For |
| Fidelity | 2,437,190 | 0 | 0 | 0 | For |
| Aberdeen | 1,029,447 | 0 | 0 | 0 | For |
| Federated Hermes | 910,597 | 0 | 0 | 0 | For |
| Charles Schwab | 870,224 | 0 | 0 | 0 | For |
| Aristotle Funds Series Trust | 829,708 | 0 | 0 | 0 | For |
| Dimensional | 704,002 | 0 | 0 | 0 | For |
| TIAA | 549,742 | 0 | 0 | 0 | For |
| Prudential/PGIM | 350,095 | 0 | 0 | 0 | For |
| Equitable | 292,368 | 0 | 0 | 0 | For |
| Pacific Life | 291,982 | 0 | 0 | 0 | For |
| Putnam | 219,346 | 0 | 0 | 0 | For |
| Goldman Sachs | 190,752 | 0 | 0 | 0 | For |
| Dunham Funds | 117,346 | 0 | 0 | 0 | For |
| Lincoln Financial | 109,576 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 104,230 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 101,932 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 90,980 | 0 | 0 | 0 | For |
| T. Rowe Price | 80,946 | 0 | 0 | 0 | For |
| 1290 Funds | 71,325 | 0 | 0 | 0 | For |
| Northern Trust | 70,987 | 0 | 0 | 0 | For |
| JPMorgan | 63,211 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 147,368,324 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.69% |
| 2 | ARK ETF Trust | 7.00% |
| 3 | MFS | 2.26% |
| 4 | BlackRock | 2.00% |
| 5 | Fidelity | 1.65% |
| 6 | Aberdeen | 0.70% |
| 7 | Federated Hermes | 0.62% |
| 8 | Charles Schwab | 0.59% |
| 9 | Aristotle Funds Series Trust | 0.56% |
| 10 | Dimensional | 0.48% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | VIKING GLOBAL INVESTORS LP | 20.35% |
| 2 | Rubric Capital Management LP | 6.87% |
| 3 | Matrix Capital Management Company, LP | 3.75% |
| 4 | Nikko Asset Management Americas, Inc. | 2.84% |
| 5 | BlackRock | 2.77% |
| 6 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.59% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.66% |
| 8 | State Street | 1.53% |
| 9 | Nikko Asset Management Co., Ltd. | 1.35% |
| 10 | PICTET ASSET MANAGEMENT SA | 1.18% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Viking Global Entities | 20.35% | DEF14A |
| BlackRock | 9.06% | 13F |
| ARK Investment Management LLC | 8.69% | 13G |
| Matrix Capital Management Master Fund, LP | 7.85% | DEF14A |
| Vanguard Group | 7.65% | 13F |
| Chad Robins | 2.73% | DEF14A |
| State Street | 1.82% | 13F |
| Goldman Sachs | 1.28% | 13F |
| Harlan Robins, PhD | 1.22% | DEF14A |
| Julie Rubinstein | 0.76% | DEF14A |
Percentages above are of 147,368,324 shares outstanding, as reported by ADAPTIVE BIOTECHNOLOGIES CORP. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ADAPTIVE BIOTECHNOLOGIES CORP.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At ADAPTIVE BIOTECHNOLOGIES CORP.'s shareholder meeting held June 7, 2024, in the 2023-2024 proxy season, 202 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,002 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, on a non-binding advisory basis, the compensation of our named executive officers… — the reporting funds and managers cast 84% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
ADAPTIVE BIOTECHNOLOGIES CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.